Designing Naturalistic Prospective Studies of Economic and Effectiveness Outcomes Associated with Novel Antipsychotic Therapies
- 1 May 2000
- journal article
- review article
- Published by Elsevier BV in Value in Health
- Vol. 3 (3), 232-242
- https://doi.org/10.1046/j.1524-4733.2000.33007.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pharmacoeconomic Evaluation in the Real WorldPharmacoEconomics, 1999
- A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory SchizophreniaNew England Journal of Medicine, 1997
- Users' Guides to the Medical LiteraturePublished by American Medical Association (AMA) ,1997
- The use of claims databases for outcomes research: rationale, challenges, and strategiesClinical Therapeutics, 1997
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Practical issues in conducting pharmacoeconomic studiesClinical Therapeutics, 1996
- The clinical-economic trial: Promise, problems, and challengesControlled Clinical Trials, 1995
- Cost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugsJournal of Clinical Epidemiology, 1995
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967